MedTech Acquisition - Warrants (18/12/2025) Long Term Debt

As of the most recent data (June 2026), MTACW shows a long-term debt of $34M. That compares with $34M in the prior-year period — up 1.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MTACW's long-term debt is now $34M (was $34M) — a 1.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether MedTech Acquisition - Warrants (18/12/2025) is outperforming or lagging.

Tracking MTACW's long-term debt over time shows whether MedTech Acquisition - Warrants (18/12/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $34M That compares with $34M in the prior-year period — up 1.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has MedTech Acquisition - Warrants (18/12/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $34M) with ownership activity and broader fundamentals.